Papapetropoulos A
(2024)
Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review.
in British journal of pharmacology
Sormani MP
(2017)
Approved drugs for multiple sclerosis: the challenge of choice.
in The Lancet. Neurology
Klein A
(2025)
Treating Niemann-Pick C lysosomal storage: approved and emerging approaches
in Trends in Molecular Medicine
Samways ML
(2023)
Water Networks in Complexes between Proteins and FDA-Approved Drugs.
in Journal of chemical information and modeling
Samways ML
(2023)
Water Networks in Complexes between Proteins and FDA-Approved Drugs.
in Journal of chemical information and modeling
Vallières C
(2020)
Repurposing Nonantifungal Approved Drugs for Synergistic Targeting of Fungal Pathogens.
in ACS infectious diseases
Samways ML
(2023)
Water Networks in Complexes between Proteins and FDA-Approved Drugs.
in Journal of chemical information and modeling
O'Reilly PG
(2016)
QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics.
in BMC bioinformatics
James JR
(2023)
Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML.
in International journal of molecular sciences
Jeffreys LN
(2019)
Novel insights into P450 BM3 interactions with FDA-approved antifungal azole drugs.
in Scientific reports
Meloni D
(2017)
EU-approved rapid tests might underestimate bovine spongiform encephalopathy infection in goats.
in Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
Meloni D
(2017)
EU-approved rapid tests might underestimate bovine spongiform encephalopathy infection in goats.
in Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
O Hagan S
(2015)
A 'rule of 0.5' for the metabolite-likeness of approved pharmaceutical drugs.
in Metabolomics : Official journal of the Metabolomic Society